CD8A and melanoma: Consistent with our result, it was reported that a B16 melanoma-specific CD8+ T cell line, AB1, expressed TCR Vβ11 [42], suggesting that clonal expansion of Vβ11+ TILs can be a useful biomarker for the T-cell response to B16 melanoma in mice.